|
|
 |
Key Data
|
(m
€) |
|
2003 |
2004 |
2005 |
2006 |
2007 |
| Net Sales |
487.5
(100%) |
488.3
(100%) |
576.1
(100%) |
576.2
(100%) |
628,4
(100%) |
| Operating Income |
81.0
(16.6%) |
90.4
(18,5%) |
111.1
(19.3%) |
120.3
(20.9%) |
131,5
(20,9%) |
| Net Income |
23.7
(4.9%) |
54.0
(11.1%) |
64.5
(11.2%) |
74.0
(12.8%) |
84,9
(13,5%) |

Net Sales

Sales by Business

Pharmaceuticals: Net Sales

Key P&L and Cash Flow
|
(m
€) |
|
2003 |
2004 |
2005 |
2006 |
2007 |
| Net Sales |
487.5 |
488.3 |
576.1 |
576.2 |
628,4 |
Gross profit
as % of Sales |
287.8
59.0% |
309.0
63.3% |
375.5
65.2% |
384.2
66.7% |
422,1
67,2% |
Operating Income
(EBIT) as % of Sales |
81.0
16.6% |
90.4
18.5% |
111.1
19.3% |
120.3
20.9% |
131,5
20,9% |
| Pretax Income |
38.4 |
86.7 |
107.0 |
118.2 |
127,4 |
| Net Income |
23.7 |
54.0 |
64.5 |
74.0 |
84,9 |
| CASH FLOW |
80.5 |
76.9 |
89.0 |
97.3 |
113,7 |

Balance Sheet Structure


Per Share Data
|
2003 |
2004 |
2005 |
2006 |
2007 |
| Earnings per share (EPS) |
0,1225 |
0,270 |
0,326 |
0,370 |
0,427 |
| Cash flow per share |
1,625 |
1,336 |
1,621 |
1,836 |
1,989 |
|
 |
|